| Name | Marks & Spencer Group |
|---|---|
| Epic | MKS |
| Isin | GB0031274896 |
| Index | UK100 UK350 |
| Industry | Personal Care, Drug and Grocery Stores |
| Latest share price | 406.30p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £8,357.85 | Debt ratio | n/a |
| Shares in issue | 2,057.06 | Debt-to-equity ratio | n/a |
| P/E ratio | 11.1 | Assets / equity ratio | n/a |
| Total dividends per share | 3.60p | Price to book value | n/a |
| Dividend yield | 1 | ROCE | 10.31 |
| Dividend cover | 8.86 | EPS growth | 30 |
| Earning per share | 14.6 | 52-week high / low | 319.30p / 411.30p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2025-05-29 | 2025-07-04 | 2.60p |
| Interim | 2024-11-28 | 2025-01-10 | 1.00p |
| Final | 2024-05-30 | 2024-07-05 | 2.00p |
| Interim | 2023-11-16 | 2024-01-12 | 1.00p |
| Company name | Marks & Spencer Group |
|---|---|
| Address | Waterside House, 35 North Wharf Road, London, United Kingdom, W2 1NW |
| Telephone | +44 (0) 20 7935 4422 |
| Website | http://corporate.marksandspencer.com/ |
| Director | Position |
|---|---|
| Mr Stuart Machin | CEO |
| Ms Alison Dolan | CFO |
| Mr Archie Norman | Chairman |
| Mr Ronan Dunne | Non-Executive Director |
| Mr Cheryl Potter | Non-Executive Director |
| Ms Fiona Dawson | Senior Independent Director |
| Mrs Tamara Ingram | Independent Non-Executive Director |
| Ms Evelyn Bourke | Independent Non-Executive Director |
| Mrs Sapna Sood | Independent Non-Executive Director |
| Assets £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Reporting date | 29/03/25 | 30/03/24 | 01/04/23 |
| Intangible asssets and goodwill | 187.4 | 179.5 | 163.1 |
| Investments and other non-current assets | 392.5 | 684.2 | 767.9 |
| Total non-current assets | 6417.7 | 6528.9 | 6942.8 |
| Inventory / work in progress | 843.9 | 776.9 | 764.4 |
| Trade and other receivables | 327.5 | 302 | 280.6 |
| Cash and equivalents | 864.5 | 1022.4 | 1067.9 |
| Other current assets and asset held for resale | 367.8 | 52 | 42.1 |
| Total of all assets | 8821.4 | 8682.2 | 9097.8 |
| Liabilities £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Short term liabilities | 2777.5 | 2516.2 | 2706.4 |
| Long term liabilities | 3092.5 | 3335.9 | 3710.6 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 5870 | 5852.1 | 6417 |
| Net assets £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net assets | 2951.4 | 2830.1 | 2680.8 |
| Equity £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Share capital | 20.6 | 20.5 | 19.8 |
| Minority interests | 11.3 | -1.1 | 4.4 |
| Retained earnings | 5888.5 | 5789.6 | 5705 |
| Share premium account | 982.7 | 967 | 910.7 |
| Total equity | 2951.4 | 2830.1 | 2680.8 |
| Income £ (m) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 624.3 | 714.2 | 515.1 |
| Pre-tax profit | 511.8 | 672.5 | 475.7 |